BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MediSys Corporation Finalizes Multi-Million Dollar Distribution Agreement With Georgia Based Medical Practice Management Firm


7/25/2006 11:18:15 AM

PALM BEACH GARDENS, Fla., July 25 /PRNewswire-FirstCall/ -- MediSys Corporation announced it has executed a definitive Distribution Agreement with Innovative Practice Solutions, Inc., a Georgia based Medical Practice Management firm. Innovative Practice Solutions (IPS) will represent MediSys Corporation as an exclusive distributor of the MaxLife Center for Men(TM) in Georgia.

IPS differs from most practice management firms by virtue of being led by successful owners of Family Medicine, Internal Medicine, Pain Management, and multidisciplinary practices. It is a performance-based and results-driven firm that provides an array of practice management services including Medical, Physical Therapy, Third Party Billing, Coding & Collections, Malpractice Claims, Marketing and Advertising, Equipment Leasing and Supplies, Diagnostic Testing Services and Multidisciplinary Structuring, among others. Currently, it serves approximately 20 medical facilities in the Georgia and Northern Florida markets and provides Mobile Diagnostic Services to approximately 300 Medical Practices nationwide.

MediSys' management estimates that this Distribution Agreement could lead to approximately 300 MaxLife Center for Men(TM) system sales. Each system retails for $69,995 and could potentially equate to $22.4 million in gross revenues during the next three years if all of the practices were to purchase a MaxLife Center for Men(TM). An additional licensing fee of $1,595 per month for each system could lead to $6.1 million per year in recurring revenues. MediSys' Chief Executive Officer Joshua Konigsberg commented, "Initial feedback from their clients has been extremely positive. We are very pleased to have such a reputable company marketing our systems." He continued, "We are thrilled about this Agreement and having the IPS become our Exclusive Representative in the Georgia market. To have a firm with their reputation, track record, experience and affiliations, will allow rapid penetration into a market that otherwise might take years to penetrate. Since IPS already has a trusted relationship with the physician it will make it easier for the physician to choose to become a licensed MaxLife Center for Men(TM). It seems that the more one knows about the business of healthcare, the more they appreciate the MaxLife Center for Men(TM) and what it can do to enhance a practice." Konigsberg added, "Depending upon the results of this Distribution Agreement, we may move forward with a hybrid approach to sales that utilize both independent distributors and dedicated sales reps."

About MediSys

MediSys Corporation provides medical diagnostic solutions to physicians in the internal medicine, family medicine and general practice markets. The Company's innovative clinical programs are easily integrated into the physicians practice, are cost-effective and enhance patient care. These programs or "systems" enable doctors to provide superior medical diagnostics & treatment while significantly improving their revenues and profits.

Disclaimer Regarding Forward-Looking Statements:

This announcement may contain certain forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.

Contact: Brian Gibson 800 Village Square Crossing Suite 201 Palm Beach Gardens, FL 33410 Tel: 561-622-5889 Fax: 561-656-2099 e-mail: investor-relations@medisyscorp.comwww.medisyscorp.com

MediSys Corporation

CONTACT: Brian Gibson of MediSys Corporation, +1-561-622-5889, or fax,+1-561-656-2099, investor-relations@medisyscorp.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->